Paper22285668
Setup variations in radiotherapy of anal cancer: advantages of target volume reduction using image-guided radiation treatment.
Chen YJ and 5 others. Int J Radiat Oncol Biol Phys, 2012. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Setup variations in radiotherapy of anal cancer: advantages of target volume reduction using image-guided radiation treatment. Papers, record 22285668. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22285668
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Setup variations in radiotherapy of anal cancer: advantages of target volume reduction using image-guided radiation treatment.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Cone-Beam Computed Tomography | Major topic |
| Prostatic Neoplasms | Major topic |
| Radiotherapy Planning, Computer-Assisted | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Humans | |
| Male | |
| Radiotherapy Dosage | |
| Reference Values | |
| Technology, Radiologic |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41815276 | Setup and target volume shape variation in rectal cancer radiotherapy: a systematic literature review. | Tech Innov Patient Support Radiat Oncol | 2026 | https://conductscience.org/library/papers/41815276 | PubMed |
| 30128811 | Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy. | Med Oncol | 2018 | https://conductscience.org/library/papers/30128811 | PubMed |
| 30002393 | Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer. | Sci Rep | 2018 | https://conductscience.org/library/papers/30002393 | PubMed |
| 29393674 | Target volume motion during anal cancer image guided radiotherapy using cone-beam computed tomography. | Br J Radiol | 2018 | https://conductscience.org/library/papers/29393674 | PubMed |
| 28740937 | Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapy. | Adv Radiat Oncol | 2017 | https://conductscience.org/library/papers/28740937 | PubMed |
| 27576432 | Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT). | Radiother Oncol | 2016 | https://conductscience.org/library/papers/27576432 | PubMed |
| 26930196 | Quantification and Assessment of Interfraction Setup Errors Based on Cone Beam CT and Determination of Safety Margins for Radiotherapy. | PLoS One | 2016 | https://conductscience.org/library/papers/26930196 | PubMed |
| 25493505 | A retrospective tomotherapy image-guidance study: analysis of more than 9,000 MVCT scans for ten different tumor sites. | J Appl Clin Med Phys | 2014 | https://conductscience.org/library/papers/25493505 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22285668
GET https://conductscience.org/api/papers/v1/22285668/authors